PP2Acα Deficiency in Vascular Smooth Muscle Cells Accelerates Aortic Aneurysm and Dissection by Regulating KLF4

Wei-Peng Hu1,2,3,4,5, Ze-Yu Cai2,6, Qing-Le Li7

  • 1Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing, 100191, China.

Insights

Protein phosphatase 2A catalytic subunit alpha (PP2Acα) deficiency worsens aortic aneurysm and dissection (AAD). PP2Acα loss impairs vascular smooth muscle cell contractility and promotes disease progression by stabilizing KLF4.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Signaling

Background:

  • Aortic aneurysm and dissection (AAD) are critical cardiovascular conditions lacking effective treatments.
  • Protein phosphatase 2A (PP2A) is a key regulator of cellular signaling pathways.
  • Understanding PP2A's role in AAD pathogenesis is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of PP2A, specifically the PP2Acα subunit, in the development of AAD.
  • To elucidate the molecular mechanisms by which PP2Acα influences vascular smooth muscle cell (VSMC) function and AAD progression.

Main Methods:

  • Analysis of human and mouse aneurysm tissue datasets.
  • Generation of VSMC-specific PP2Acα knockout mouse models.
  • In vivo induction of aortic dissection and aneurysm using BAPN and elastase.
  • In vitro assays including collagen-based contraction, Western blot, and gelatin zymography.

Main Results:

  • PP2Acα was significantly downregulated in human and mouse aneurysm tissues.
  • VSMC-specific PP2Acα knockout exacerbated AAD in mice.
  • PP2Acα deficiency decreased VSMC contractility, reduced contractile markers, and increased MMP2 production.
  • PP2Acα deficiency stabilized KLF4, promoting VSMC phenotypic switching and suppressing contractile gene transcription via AKT1 signaling.

Conclusions:

  • PP2Acα plays a critical protective role in regulating VSMC function and preventing AAD.
  • PP2Acα deficiency promotes AAD by controlling KLF4 phosphorylation and subsequent degradation.
  • Targeting PP2Acα-KLF4 interaction may offer a novel therapeutic strategy for AAD.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K